Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help ...

Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving closer to approval. The opioid epidemic in the ...

The hope is that a new generation of non-opioid analgesics will become available to treat both acute and chronic pain and have a reduced risk of addiction. In 2023, more than 100,000 lives were ...

Advances Pacira’s “5x30” path to becoming an innovative biopharmaceutical organization -- -- Adds novel, high-capacity, local ...

One way to address the opioid crisis is to clear away red tape and make other pain treatments more easily available, Rep.

Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, and Grünenthal, a global leader in pain management ...

Leaders with Project Opioid, a non-profit established after the opioid epidemic was declared a public health emergency in 2017, said the trend of declining overdose deaths is encouraging, but there is ...

Behind pharmacy counters across Arkansas, pharmacists serve as the link between health-care providers and patients managing pain. While they work diligently to ensure safe medication use and counsel ...

The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.